NLRP3’s impact on tumorigenesis is complex, demonstrating both anti-tumorigenic effects, notably observed in colitis-associated colorectal cancer (CAC), and tumor-promoting effects, as seen in gastric and skin cancers [47]. This evidence concerns the gene NLRP3 and colorectal cancer.